IMAX Corporation Reports Third Quarter 2013 Financial Results

HIGHLIGHTS

- IMAX signs contracts for 99 theatres in the third quarter, bringing year-to-date signings to 158

- IMAX expands backlog to historical high of 356 theatres, a 25% increase year-over-year

- Third quarter box office of $133 million brings year-to-date box office to $482 million, a 3% increase year-over-year

24 Oct, 2013, 07:00 ET from IMAX Corporation

NEW YORK, Oct. 24, 2013 /PRNewswire/ -- IMAX Corporation (NYSE: IMAX; TSX:IMX) today reported third quarter 2013 revenues of $51.7 million, adjusted EBITDA as calculated in accordance with the Company's credit facility of $14.8 million, adjusted net income of $4.4 million, or $0.06 per diluted share, and reported net income of $1.6 million, or $0.02 per diluted share.  

(Logo: http://photos.prnewswire.com/prnh/20111107/MM01969LOGO )

"We continued to make significant progress this quarter toward our key strategic initiatives, including strong signings, controlling SG&A and continued advancements on differentiation," stated Richard L. Gelfond, IMAX Chief Executive Officer. "Looking ahead, our great start to Q4, including IMAX's strong performance on Gravity and Stalingrad, reminds us of the importance of assessing our portfolio of films on an annual basis, which we believe is a relatively predictable driver of box office performance over the long-term."

Network Growth Update

The total IMAX® theatre network consisted of 785 systems as of September 30, 2013, of which 653 were in commercial multiplexes. There were 356 theatre systems in backlog as of September 30, 2013, compared to 285 theatre systems in backlog as of September 30, 2012.  IMAX has signed contracts for 158 theatres year-to-date, already surpassing the 142 signings for all of 2012.  Neither the backlog number, nor the YTD signings, include the 80 additional theatres still optional under the Wanda contract.  For a breakdown of theatre system signings, installations, network and backlog by type, please see the end of this press release.

In the third quarter of 2013, the Company signed contracts for 99 theatre systems, of which 88 were in new theatre locations and 11 were a combination of signings for laser systems and upgrades of certain of the Company's film theatres to digital systems in existing theatre locations.  In the quarter, the Company installed 28 theatre systems, of which 19 were in new theatre locations. 

"Strong third quarter signings, historic high backlog and many fourth quarter deals either signed or in discussions, provide increased visibility into strong network growth over the long-term," Gelfond continued, "This unit growth, along with our ongoing focus on controlling costs and optimizing our film portfolio, give us confidence in our operating leverage and cash flow potential for the long-term."

Third-Quarter Segment Results

  • Revenue from sales and sales-type leases was $6.4 million in the third quarter of 2013, compared to $21.9 million in the third quarter of 2012, primarily reflecting the installation of 5 full, new theatre systems under sales and sales-type lease arrangements in the most recent third quarter, compared to the 14 sales and sales-type theatres the Company installed in the third quarter of 2012.  The Company also installed 1 operating lease in a new location.  In addition there were 9 digital system upgrades in existing locations in the third quarter of 2013, compared to 5 upgrades in the third quarter of 2012.
  • Revenue from joint revenue-sharing arrangements was $12.0 million in the quarter, compared to $13.2 million in the prior-year period.  During the quarter, the Company installed 13 new theatres under joint revenue-sharing arrangements, compared to 14 in the year-ago period.  The Company had 351 theatres operating under joint revenue-sharing arrangements as of September 30, 2013, as compared to 287 theatres one year prior.
  • Production and IMAX DMR® (Digital Re-Mastering) revenues were $14.5 million in the third quarter of 2013, compared to $25.2 million in the third quarter of 2012.  Gross box office from DMR titles was $132.5 million in the third quarter of 2013, compared to $173.2 million in the prior-year period.  The average global DMR box office per screen in the third quarter of 2013 was $207,500 compared to $312,000 in the prior-year period.

Conference Call

The Company will host a conference call today at 8:30 AM ET to discuss its third quarter 2013 financial results.  To access the call via telephone, interested parties should dial (800) 711-9538 approximately 5 to 10 minutes before it begins.  International callers should dial (416) 640-5925. The participant passcode for the call is 1695965. This call is also being webcast by Thomson Financial and can be accessed on the 'Investor Relations' section of www.imax.com.  A replay of the call will be available via webcast on the 'Investor Relations' section of www.imax.com or via telephone by dialing (888) 203-1112 (US and Canada) or (647) 436-0148 (international). The Conference ID for the telephone replay is 1695965.

About IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX theatres to connect with audiences in extraordinary ways, and, as such, IMAX's network is among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto and Los Angeles, with offices in London, Tokyo, Shanghai and Beijing.  As of September 30, 2013, there were 785 IMAX theatres (653 commercial multiplexes, 19 commercial destinations and 113 institutions) in 55 countries.

IMAX®, IMAX® 3D, IMAX DMR®, Experience It In IMAX®, An IMAX 3D Experience®, The IMAX Experience®, IMAX Is Believing® and IMAX nXos® are trademarks of IMAX Corporation. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).

This press release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, general economic, market or business conditions; the opportunities (or lack thereof) that may be presented to and pursued by the Company; the performance of IMAX DMR films; competitive actions by other companies; conditions in the in-home and out-of-home entertainment industries; the signing of theater system agreements; changes in laws or regulations; conditions, changes and developments in the commercial exhibition industry; the failure to convert theater system backlog into revenue; risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company's growth and operations in China; the failure to respond to change and advancements in digital technology; risks related to the acquisition of AMC Entertainment Holdings, Inc. by Dalian Wanda Group Co., Ltd.; risks related to new business initiatives; the potential impact of increased competition in the markets within which the Company operates; risks related to the Company's inability to protect the Company's intellectual property; risks related to Eastman Kodak bankruptcy and the possibility of constrained film supply; risks related to the Company's implementation of a new enterprise resource planning system; risks related to the Company's prior restatements and the related litigation; and other factors, many of which are beyond the control of the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

For additional information please contact:

Investors:

IMAX Corporation, New York

Teri Loxam

212-821-0100

tloxam@imax.com

 

Business Media:

Sloane & Company, New York

Whit Clay

212-446-1864

wclay@sloanepr.com

Media:

IMAX Corporation, New York

Ann Sommerlath

212-821-0155

asommerlath@imax.com

 

Entertainment Media:

Principal Communications Group, Los Angeles

Melissa Zuckerman/Paul Pflug

323-658-1555

melissa@pcommgroup.com

paul@pcommgroup.com

 

Additional Information

Signings and Installations

Sep. 30, 2013

Three Months

Ended Sep. 30,

Theatre Signings:

2013

2012

Full new sales and sales-type lease arrangements

6

4

New joint revenue sharing arrangements

82

28

  Total new theatres

88

32

Upgrades of IMAX theatre systems

11

(1)

9

(2)

Total Theatre Signings

99

41

Three Months

Ended Sep. 30,

Theatre Installations:

2013

2012

Full new sales and sales-type lease arrangements

6

(3)

14

New joint revenue sharing arrangements

13

14

  Total new theatres

19

28

Upgrades of IMAX theatre systems

9

(1)

5

Total Theatre Installations

28

33

As of Sep. 30,

Theatre Backlog:

2013

2012

New sales and sales-type lease arrangements

142

133

New joint revenue sharing arrangements

191

149

  Total new theatres

333

282

Upgrades of IMAX theatre systems

23

3

Total Theatres in Backlog

356

(4)

285

 (5)

As of Sep. 30,

Theatre Network:

2013

2012

Commercial Multiplex Theatres:

Sales and sales-type lease arrangements

302

269

Joint revenue sharing arrangements

351

287

Total Commercial Multiplex Theatres

653

556

Commercial Destination Theatres

19

20

Institutional Theatres

113

113

Total IMAX Theatre Network

785

689

(1) Includes upgrades to xenon-based digital systems under short-term operating lease arrangements (4 signings, 3 installations).

(2) Includes 3 IMAX theaters acquired from another existing customer that has been operating under a joint revenue sharing arrangement. These theaters were purchased from the Company under a sales arrangement.

(3) Includes one full xenon-based digital system under a short-term operating lease arrangement.

(4) Includes 23 upgrades to a digital theater system, in an existing IMAX theater location (5 xenon, 18 laser of which 3 are under joint revenue sharing arrangements).

(5) Includes 3 upgrades to a digital theater system, in an existing IMAX theater location (2 xenon, 1 laser).

Additional Information (continued)

2013 DMR Films Announced to Date:  

To date, IMAX has announced 37 titles to be released in 2013.  The Company released 35 titles in 2012.  The Company remains in discussions with virtually every major studio regarding future titles and expects the total number of titles in 2013 to be similar to that in 2012. 

  • The Grandmaster: The IMAX Experience (Jet Tone Films and Sil-Metropole Organization, January 2013, China only);
  • Hansel & Gretel: Witch Hunters: An IMAX 3D Experience (Paramount Pictures, January 2013);
  • Journey to the West: Conquering the Demons: An IMAX 3D Experience (Bingo Movie Development Ltd, February 2013, China only);
  • Top Gun: An IMAX 3D Experience (Paramount Pictures, February 2013);
  • A Good Day to Die Hard: The IMAX Experience (Twentieth Century Fox, February 2013);
  • Jack the Giant Slayer: An IMAX 3D Experience (Warner Bros., March 2013);
  • Oz: The Great and Powerful: An IMAX 3D Experience (Walt Disney Pictures, March 2013);
  • G.I. Joe: Retaliation: An IMAX 3D Experience (Paramount Pictures, March 2013);
  • Dragon Ball Z: Battle of the Gods: An IMAX 3D Experience (Toei Animation Company, March 2013, Japan only);
  • Jurassic Park: An IMAX 3D Experience (Universal Pictures, April 2013);
  • Oblivion: The IMAX Experience (Universal Pictures, April 2013);
  • Iron Man 3: An IMAX 3D Experience (Walt Disney Pictures, May 2013);
  • Star Trek: Into Darkness: An IMAX 3D Experience (Paramount Pictures, May 2013);
  • Fast & Furious 6: The IMAX Experience (Universal, May 2013, international only);
  • After Earth: The IMAX Experience (Sony, May 2013);
  • Man of Steel: The IMAX Experience (Warner Bros., June 2013);
  • World War Z: An IMAX 3D Experience (Paramount Pictures, June 2013, international only);
  • Despicable Me 2: An IMAX 3D Experience (Universal Pictures, July 2013, international only);
  • White House Down: The IMAX Experience (Colombia Pictures and Sony Pictures, July 2013; international only);
  • Man of Tai Chi: The IMAX Experience (China Film Group, Wanda Group and Village Roadshow Pictures, July 2013; China only);
  • Pacific Rim: An IMAX 3D Experience (Warner Bros., July 2013);
  • The Lone Ranger : The IMAX Experience (Walt Disney Pictures, August 2013; international only);
  • Elysium: The IMAX Experience (Sony, August 2013);
  • Riddick Sequel: The IMAX Experience (Universal Pictures, September 2013);
  • Mortal Instruments: City of Bones: The IMAX Experience (Sony, August 2013; domestic only);
  • The Wizard of Oz: An IMAX 3D Experience (Warner Bros., September 2013; domestic only);
  • Metallica Through the Never: An IMAX 3D Experience (Picturehouse, September 2013);
  • Young Detective Dee: The IMAX Experience (Huayi Brothers, September 2013; China only);
  • Stalingrad: An IMAX 3D Experience (AR Films, October 2013; Russia and the CIS only );
  • Gravity: An IMAX 3D Experience (Warner Bros., October 2013);
  • Captain Phillips: The IMAX Experience (Colombia Pictures and Sony Pictures, October 2013);
  • The Young and Prodigious: T.S. Spivet: An IMAX 3D Experience (Gaumont, October 2013; France only);
  • Ender's Game: The IMAX Experience (Lionsgate, November 2013);
  • Thor: The Dark World: An IMAX 3D Experience (Walt Disney Pictures, November 2013; international only);
  • The Hunger Games: Catching Fire: The IMAX Experience (Lionsgate, November 2013);
  • The Hobbit: The Desolation of Smaug: An IMAX 3D Experience (Warner Bros., December 2013); and
  • Dhoom 3: The IMAX Experience (Yash Raj Films, 2013, India only).

 

 

IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars, except per share amounts)

(Unaudited)

Three Months

Nine Months

Ended September 30,

Ended September 30,

2013

2012*

2013

2012*

Revenues

Equipment and product sales

$

9,623

$

24,327

$

40,649

$

55,756

Services

29,061

40,316

98,019

102,312

Rentals

10,987

14,013

38,782

42,912

Finance income

2,071

2,055

6,079

5,537

Other

-

-

375

-

51,742

80,711

183,904

206,517

Costs and expenses applicable to revenues

Equipment and product sales

4,086

10,652

20,561

27,727

Services

16,339

21,107

54,783

55,378

Rentals

4,059

4,202

11,687

12,968

Other

-

-

-

-

24,484

35,961

87,031

96,073

Gross margin

27,258

44,750

96,873

110,444

Selling, general and administrative expenses

19,778

19,432

59,364

59,032

(including share-based compensation expense of $2.8 million and $8.8 million for the three and nine months ended September 30, 2013, respectively (2012 - expense of $2.8 million and $10.3 million, respectively))

Research and development

3,974

2,528

11,267

7,623

Amortization of intangibles

409

166

1,146

532

Receivable provision, net of recoveries

224

241

279

829

Impairment of available-for-sale investment

-

-

-

150

Income from operations

2,873

22,383

24,817

42,278

Interest income

14

22

39

73

Interest expense

(315)

(373)

(1,008)

(1,375)

Income from operations before income taxes

2,572

22,032

23,848

40,976

Provision for income taxes

(619)

(6,787)

(6,564)

(11,484)

Loss from equity-accounted investments

(344)

(334)

(998)

(1,038)

Net income

$

1,609

$

14,911

$

16,286

$

28,454

Net income per share - basic & diluted:

Net income per share - basic

$

0.02

$

0.23

$

0.24

$

0.43

Net income per share - diluted

$

0.02

$

0.22

$

0.24

$

0.42

Weighted average number of shares outstanding (000's):

Basic

67,309

65,930

66,969

65,718

Fully Diluted

69,116

68,301

68,853

68,187

Additional Disclosure:

Depreciation and amortization(1)

$

8,826

$

8,038

$

29,027

$

24,704

(1) Includes $0.1 million and $0.3 million of amortization of deferred financing costs charged to interest expense for the three and nine months ended September 30, 2013, respectively (2012 - less than $0.1 million and $0.1 million, respectively).

* Reflects a revision resulting from an adjustment to reflect an unfunded postretirement obligation of the Company.

 

IMAX CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

In accordance with United States Generally Accepted Accounting Principles

(in thousands of U.S. dollars)

As at

As at

September 31,

December 31,

2013

2012

(unaudited)

Assets

Cash and cash equivalents

$

25,955

$

21,336

Accounts receivable, net of allowance for doubtful accounts of $1,513 (December 31, 2012 — $1,564)

44,321

42,007

Financing receivables

99,591

94,193

Inventories

14,306

15,794

Prepaid expenses

4,576

3,833

Film assets

6,305

3,737

Property, plant and equipment

126,930

113,610

Other assets

27,739

23,963

Deferred income taxes

31,052

36,461

Goodwill

39,027

39,027

Other intangible assets

27,688

27,911

Total assets

$

447,490

$

421,872

Liabilities

Bank indebtedness

$

5,000

$

11,000

Accounts payable

17,051

15,144

Accrued and other liabilities

67,181

68,695

Deferred revenue

73,789

73,954

Total liabilities

163,021

168,793

Shareholders' equity

Capital stock, common shares — no par value. Authorized — unlimited number.

    Issued and outstanding — 67,518,740 (December 31, 2012 — 66,482,425)

323,744

313,744

Other equity

33,642

28,892

Deficit

(70,880)

(87,166)

Accumulated other comprehensive loss

(2,037)

(2,391)

Total shareholders' equity

284,469

253,079

Total liabilities and shareholders' equity

$

447,490

$

421,872

 

IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars)

(Unaudited)

Nine Months

Ended September 30,

2013

2012*

Cash provided by (used in):

Operating Activities

Net income

$

16,286

$

28,454

Adjustments to reconcile net income to cash from operations:

Depreciation and amortization

29,027

24,704

Write-downs, net of recoveries

279

1,516

Change in deferred income taxes

5,579

9,431

Stock and other non-cash compensation

9,348

11,099

Gain on curtailment of postretirement benefits

(2,185)

-

Unrealized foreign currency exchange loss (gain)

275

(152)

Loss from equity-accounted investments

998

1,038

Investment in film assets

(16,772)

(13,508)

Changes in other non-cash operating assets and liabilities

(9,860)

(8,672)

Net cash provided by operating activities

32,975

53,910

Investing Activities

Purchase of property, plant and equipment

(6,167)

(2,599)

Investment in joint revenue sharing equipment

(16,363)

(15,174)

Investment in new business ventures

(2,500)

(381)

Acquisition of other intangible assets

(1,812)

(5,046)

Net cash used in investing activities

(26,842)

(23,200)

Financing Activities

Increase in bank indebtedness

12,000

9,917

Repayment of bank indebtedness

(18,000)

(35,000)

Common shares issued - stock options exercised

6,745

5,831

Credit facility amendment fees paid

(2,089)

-

Share issuance expenses

(202)

-

Net cash used in financing activities

(1,546)

(19,252)

Effects of exchange rate changes on cash

32

(146)

Increase in cash and cash equivalents during the period

4,619

11,312

Cash and cash equivalents, beginning of period

21,336

18,138

Cash and cash equivalents, end of period

$

25,955

$

29,450

 

IMAX CORPORATION SELECTED FINANCIAL DATA In accordance with United States Generally Accepted Accounting Principles (in thousands of U.S. dollars)

The Company has seven reportable segments identified by category of product sold or service provided: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production; and other. The IMAX systems segment is comprised of the design, manufacture, sale or lease IMAX theater projection system equipment. The theater system maintenance segment consists of the maintenance of IMAX theater projection system equipment in the IMAX theater network. The joint revenue sharing arrangements segment is comprised of the installation IMAX theater projection system equipment to an exhibitor in exchange for a certain percentage of box-office receipts, concession revenue and in some cases a small upfront or initial payment. The film production and IMAX DMR segment is comprised of the production of films and performance of film re-mastering services. The film distribution segment includes the distribution of films for which the Company has distribution rights. The film post-production segment includes the provision of film post-production and film print services. The other segment includes certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items.

Three Months

Nine Months

Ended September 30,

Ended September 30,

2013

2012

2013

2012

Revenue

IMAX Theater Systems

IMAX Systems

Sales and sales-type leases

$

6,419

$

21,937

$

33,321

$

49,751

Ongoing rent, fees, and finance income

3,483

3,421

10,111

9,312

Other

2,230

4,997

8,362

10,394

12,132

30,355

51,794

69,457

Theater system maintenance

8,103

7,042

23,844

20,878

Joint revenue sharing arrangements

11,960

13,186

39,672

40,477

Film

Production and IMAX DMR

14,547

25,223

54,854

58,805

Film distribution and post-production

5,000

4,905

13,740

16,900

19,547

30,128

68,594

75,705

Total

$

51,742

$

80,711

$

183,904

$

206,517

Gross margins

IMAX Theater Systems

IMAX systems(1)

Sales and sales-type leases

$

3,928

$

12,575

$

16,390

$

25,259

Ongoing rent, fees, and finance income

3,277

3,381

9,758

9,216

Other

(302)

564

(29)

287

6,903

16,520

26,119

34,762

Theater system maintenance

3,218

2,828

9,432

8,122

Joint revenue sharing arrangements(1)

7,153

9,286

26,796

28,340

Film

Production and IMAX DMR(1)

8,596

15,426

30,372

35,714

Film distribution and post-production

1,388

690

4,154

3,506

9,984

16,116

34,526

39,220

Total

$

27,258

$

44,750

$

96,873

$

110,444

(1) IMAX systems include commission costs of $0.2 million and $0.9 million for the three and nine months ended September 30, 2013, respectively (2012 — $0.9 million and $2.1 million, respectively). Joint revenue sharing arrangements segment margins include advertising, marketing and commission costs of $0.9 million and $2.0 million for the three and nine months ended September 30, 2013, respectively (2012 — $1.1 million and $2.1 million, respectively). Production and IMAX DMR segment margins include marketing costs of $0.8 million and $3.1 million for the three and nine months ended September 30, 2013, respectively (2012 — $0.5 million and $2.2 million, respectively). Distribution segment margins include a marketing cost of $0.1 million and $0.2 million for the three and nine months ended September 30, 2013, respectively (2012 — recovery of less than $0.1 million and an expense of $1.2 million, respectively).

IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)

Non-GAAP Financial Measures:

In this release, the Company presents adjusted EBITDA, adjusted net income and adjusted net income per diluted share as supplemental measures of performance of the Company, which are not recognized under United States generally accepted accounting principles ("GAAP"). The Company presents adjusted EBITDA, adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its variable share-based compensation, provision for arbitration award and deferred taxes on its net income. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted EBITDA, adjusted net income and adjusted net income per diluted share should be considered in addition to, and not as a substitute for, net income and other measures of financial performance reported in accordance with GAAP.

Adjusted EBITDA is calculated on a basis consistent with the Company's Credit Facility, which refers to Adjusted EBITDA as EBITDA. The Credit Facility provides that the Company will be required to maintain a Fixed Charge Coverage Ratio (as defined in the Credit Agreement) of not less than 1.1:1. The Company will also be required to maintain minimum EBITDA (as defined in the Credit Agreement) of $70.0 million between closing and September 30, 2013, which requirement increases to $80.0 million on December 31, 2013, $90.0 million on December 31, 2014, and $100.0 million on December 31, 2015. The Company must also maintain a Maximum Total Leverage Ratio (as defined in the Credit Agreement) of 2.5:1 between closing and September 30, 2013, which requirement decreases to (i) 2.25:1 on December 31, 2013; (ii) 2.00:1 on December 31, 2014; and (iii) 1.75:1on December 31, 2015. The ratio of total debt to EBITDA was 0.06:1 as at September 30, 2013, where Total Debt (as defined in the Credit Agreement) is the sum of all obligations evidenced by notes, bonds, debentures or similar instruments and was $5.0 million. EBITDA is calculated as follows:

3 months ended

12 months ended

September 30, 2013

September 30, 2013(1)

(In thousands of U.S Dollars)

Net income

$

1,609

$

29,169

Add:

Loss from equity accounted investments

344

1,322

Provision for income taxes

619

10,159

Interest expense, net of interest income

301

271

Depreciation and amortization, including film asset amortization

8,699

36,716

Write-downs net of recoveries including asset impairments and receivable provisions

224

370

Stock and other non-cash compensation

3,031

12,469

Gain on curtailment of postretirement benefits

-

(2,185)

$

14,827

$

88,291

 (1) Ratio of funded debt calculated using twelve months ended EBITDA.

 

IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)

Adjusted Net Income and Adjusted Diluted Per Share Calculations – Quarter Ended September 30, 2013 vs. 2012:

The Company reported net income of $1.6 million or $0.02 per basic and diluted share for the third quarter of 2013, as compared to net income of $14.9 million or $0.23 per basic share and $0.22 per diluted share for the third quarter of 2012. The quarter ended September 30, 2012 included the exceptional performance of The Dark Knight Rises: The IMAX Experience. Net income for the third quarter of 2013 includes a $2.8 million charge, or $0.04 per diluted share, for stock-based compensation (2012 - $2.8 million or $0.04 per diluted share). Adjusted net income, which consists of net income excluding stock-based compensation expense and the related tax impact, was $4.4 million, or $0.06 per diluted share, in the third quarter of 2013, as compared to adjusted net income of $17.8 million, or $0.26 per diluted share, for the third quarter of 2012. A reconciliation of net income, the most directly comparable U.S. GAAP measure, to adjusted net income and adjusted net income per diluted share is presented in the table below:

Three Months Ended

Three Months Ended

September 30, 2013

September 30, 2012

Net Income

Diluted EPS

Net Income

Diluted EPS

Reported

$

1,609

$

0.02

$

14,911

$

0.22

Adjustments:

Stock-based compensation

2,838

0.04

2,756

0.04

Tax benefit on item listed above

(85)

-

114

-

Adjusted

$

4,362

$

0.06

$

17,781

$

0.26

Weighted average diluted shares outstanding

69,116

68,301

 

Adjusted Net Income and Adjusted Diluted Per Share Calculations – Nine Months Ended September 30, 2013 vs. 2012:

The Company reported net income of $16.3 million or $0.24 per basic and diluted share for the nine months ended September 30, 2013, as compared to net income of $28.5 million or $0.43 per basic and $0.42 per diluted share for the nine months ended September 30, 2012. Net income for the nine months ended September 30, 2013 includes a $8.8 million charge, or $0.12 per diluted share, for stock-based compensation (2012 – $10.3 million or $0.15 per diluted share). Adjusted net income, which consists of net income excluding stock-based compensation expense and the related tax expense, was $24.9 million, or $0.36 per diluted share, in the nine months ended September 30, 2013, as compared to adjusted net income of $38.6 million, or $0.57 per diluted share, for the nine months ended September 30, 2012. A reconciliation of net income, the most directly comparable U.S. GAAP measure, to adjusted net income and adjusted net income per diluted share is presented in the table below:

Nine Months

Nine Months

Ended September 30, 2013

Ended September 30, 2012

Net Income

Diluted EPS

Net Income

Diluted EPS

Net income

$

16,286

$

0.24

$

28,454

$

0.42

Add:

Stock-based compensation

8,772

0.12

10,252

0.15

Tax expense on items listed above

(159)

-

(86)

-

Adjusted net income

$

24,899

$

0.36

$

38,620

$

0.57

Weighted average diluted shares outstanding

68,853

68,187

 

Free Cash Flow:

Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company's after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. A reconciliation of cash provided by operating activities to free cash flow is presented in the table below:

Nine Months Ended

(In thousands of U.S. Dollars)

September 30, 2013

Net cash provided by operating activities  

$

32,975

Net cash (used in) investing activities 

(26,842)

Free cash flow

$

6,133

 

SOURCE IMAX Corporation



RELATED LINKS

http://www.imax.com